Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ORPHENADRINE CITRATE

ORPHENADRINE CITRATE

Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview ORPHENADRINE CITRATE is listed in Drugs@FDA under application 091158 (ANDA).

Marketing status: Prescription Active ingredient ORPHENADRINE CITRATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 100MG Sponsor UNICHEM Submission history Latest submission status date: 2012-07-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORPHENADRINE CITRATE is listed in Drugs@FDA under application 091158 (ANDA). Marketing status: Prescription Active ingredient ORPHENADRINE CITRATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 100MG Sponsor UNICHEM Submission history Latest submission status date: 2012-07-27 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: UNKNOWN
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
ORPHENADRINE CITRATE (ORPHENADRINE CITRATE) | Drug Monograph | MedicHelpline